Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant. Curr. Issues Mol. Biol. 2025, 47, 680

Puntos clave

• The aim is to assess the effects of the organofluorine hydrazone antioxidant HY-12 on oxidative stress and angiogenesis related to preeclampsia.
• Developed an in vitro model of preeclampsia.
• Administered HY-12 to assess its effects.
• Measured markers of oxidative stress and angiogenesis.
• HY-12 significantly reduced oxidative stress markers.
• Improvements in angiogenic activity were observed.
• Suggests therapeutic potential for managing preeclampsia.